Status:

WITHDRAWN

Behavioral Therapy Development for Methamphetamine Abusers

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings

Eligibility:

MALE

18-65 years

Phase:

PHASE2

Brief Summary

The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to tre...

Eligibility Criteria

Inclusion

  • HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65
  • Willing to give informed consent and comply with study procedures;
  • Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications;
  • Diagnosed with current methamphetamine abuse as determined by MINI; and
  • Interested in seeking treatment for their methamphetamine abuse and in participating in this research project.

Exclusion

  • Unwilling to give, or withdrawal of, informed consent;
  • Inability to understand nature of study;
  • A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder);
  • Current suicidal ideation or suicide attempt within the past 3 months; and
  • Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
  • Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00249678

Start Date

September 1 2004

End Date

May 1 2007

Last Update

February 17 2020

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

UCLA Medical Center

Los Angeles, California, United States, 90024

2

UCLA, Integrated Substance Abuse Programs

Los Angeles, California, United States, 90024

3

UCLA CARE Clinic

Los Angeles, California, United States, 90035